Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
about
Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis: New Perpectives and UpdateCurrent concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A reviewStem cell transplantation for motor neuron disease: current approaches and future perspectivesRecent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral SclerosisControlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantationHuman glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALSExtensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord.Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.Potential of immunosuppressive agents in cerebral ischaemia.Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell linesStem cell technology for neurodegenerative diseases.Strategies for enrichment and selection of stem cell-derived tissue precursors.Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?Functional recovery in rats with ischemic paraplegia after spinal grafting of human spinal stem cellsStem cell therapy for amyotrophic lateral sclerosisHost induction by transplanted neural stem cells in the spinal cord: further evidence for an adult spinal cord neurogenic niche.Neonatal Immune Tolerance Induction to Allow Long-Term Studies With an Immunogenic Therapeutic Monoclonal Antibody in MiceAmelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation.Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trialsImmunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury.Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitryTransplantation of human fetal-derived neural stem cells improves cognitive function following cranial irradiation.Stem cells in amyotrophic lateral sclerosis: state of the art.Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies.Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research.Adult human neural stem cell therapeutics: Current developmental status and prospectA retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.Cord blood as a potential therapeutic for amyotrophic lateral sclerosis.Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiationSuppression of Etk/Bmx protects against ischemic brain injury.Cell-Based Neurorestorotherapy in Amyotrophic Lateral Sclerosis - Scientific Truth should Rely on Facts, but Not Conjecture.Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosisNeural stem cells as a therapeutic approach for amyotrophic lateral sclerosis.Commentary on "the promise and the reality of stem-cell therapies for neurodegenerative diseases"Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease.Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
P2860
Q24630353-FFD416C9-28A4-4D30-B8F7-7E0691551464Q26781051-35BFE37C-B0BB-410B-AE77-266FE4B0D811Q26861926-01AC1DF0-19E1-42F9-A1F6-D0F8157D8D32Q26995278-FC878E2D-F1B1-4A28-9DE0-CB2C8ED4B45DQ27338320-22997A32-4DCA-40E0-AF44-A529E8CDDC35Q28543575-4BA43387-728D-401F-84F2-0CA16A18F525Q28744203-F521D350-211A-41C8-9C3F-475A2312A608Q33273600-BA2EF0E6-AD0B-4DC4-A1FB-2E45CCFE94A6Q33919781-0EDA6B80-358B-4C5D-844D-02CC08EECC4CQ34595662-58ED81D2-2290-4447-A038-E6D49DF32AB5Q34994432-82C09FDD-ABC0-4952-8F2D-93530C2AC664Q34999388-C562695D-5C1F-428F-BAB0-116DFF8538D6Q35116680-B05C4288-2E28-46C2-82C0-FCFCEC616B98Q35224202-C5B35C00-C6FF-45BB-BC42-8974DD73072FQ36084810-B893B37A-5981-4DB5-9D8E-1CF4699DD94AQ36111849-E57BCADC-74FC-4B41-AA77-F76AAD92AE71Q36158013-878C30E0-C061-4ECD-82AA-948B0EEB8AB2Q36301821-6065D6BB-D2FF-44D2-A639-7E69E93A1C74Q36570398-34AEDA10-4CA8-4E68-9167-CF48651A0BF7Q36653919-F0492884-9721-448A-AF86-404F179C7AE8Q36998177-5C01F877-8D9A-46E0-A312-CF41A39EBA97Q37158966-84C67837-9274-4DA6-AB9E-C9627DCAE95BQ37202715-5539FBFD-E8A5-41BE-8ACC-C6DE26255E52Q37290026-F02A191A-C74C-49AC-AA08-D1AC0B2517E2Q37307371-93FD5066-3AEB-486D-B10E-78EF9FF0B15FQ37491169-3E12C31E-A7B6-41A9-A63D-A7E2D63DF332Q37575591-B199D861-17A3-48B3-8E82-3CCBF97E1072Q37586955-FA81234E-7CE7-4A6A-89EC-AD7CF0B2DC9EQ38015343-EA57703E-DF52-4F81-8DEC-842CB814D44BQ38332493-22E085F3-0C79-4EC4-88BF-3CB7EDF83D6DQ38573829-0D799F42-B90C-43B4-A5E7-36190056B7B5Q38690849-4E566F6B-DB98-42B2-9231-DFAF080F92E7Q38875361-7249AE9C-83EB-44E2-9FB6-79FAEB7E062EQ39471822-8F74B124-FB35-42EF-BCC4-E5DFA2506E29Q39946077-6E7BAE98-CBA3-497B-9C7E-E80FE8060993Q40884175-F7E8550C-E2D6-4784-8C67-2D8D290F3833Q41574283-A364BC2B-D367-4EB2-B023-AE91B0E4F6ACQ41860492-72AB4856-1515-452D-A7E4-3804DCBB4D2FQ42188656-DE8D0292-C56F-40A1-A12B-20E4532A8626Q43297575-DC07215D-FCBE-4458-BDE3-22AF76C7B279
P2860
Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Combined immunosuppressive age ...... ral sclerosis transgenic mice.
@en
Combined immunosuppressive age ...... ral sclerosis transgenic mice.
@nl
type
label
Combined immunosuppressive age ...... ral sclerosis transgenic mice.
@en
Combined immunosuppressive age ...... ral sclerosis transgenic mice.
@nl
prefLabel
Combined immunosuppressive age ...... ral sclerosis transgenic mice.
@en
Combined immunosuppressive age ...... ral sclerosis transgenic mice.
@nl
P2093
P1433
P1476
Combined immunosuppressive age ...... ral sclerosis transgenic mice.
@en
P2093
Annie M Welsh
David Chen
Thomas Hazel
Vassilis E Koliatsos
P304
P356
10.1634/STEMCELLS.2005-0518
P577
2006-04-27T00:00:00Z